Sumitomo Pharma Co., Ltd. engages in manufacture, sale, import, and export of pharmaceutical products. The company is headquartered in Osaka, Osaka-Fu and currently employs 3,832 full-time employees. The firm operates through three geographical segments. The Japan segment is engaged in the manufacture, purchase, and sale of prescription drugs, purchase and sale of medical devices, undertakes development and manufacture in the field of regenerative medicine and cellular medicine, and the manufacture of pharmaceuticals, medical devices, and regenerative medicine products that have been developed through joint development in the field of regenerative medicine. This segment also provides storage and delivery service of pharmaceuticals. The North America segment is engaged in the manufacture, purchase, and sale of prescription drugs. The Asia segment is engaged in the manufacture and sale of prescription drugs (small packaging), and the import, purchase and sale of prescription drugs in Southeast Asia and Taiwan, as well as the provision and collection of information on products.
Sumitomo Pharma Co., Ltd. hisse başına yıllık % {var1} temettüye sahiptir ve % {var2} oranında bir getiri sunmaktadır. Temettü altı ayda bir ödenmektedir ve son temettü hariç tarihi Mar 30, 2023 tarihindedir.
Dividend Yield
Yıllık Dividende
Özsermaye Tarihi
0.00%
$0.0076
Mar 30, 2023
Ödeme Sıklığı
Ödeme Oranı
Altı ayda bir
0.00%
Dividend History
Özsermaye Tarihi
Nakit Tutarı
Kayıt Tarihi
Ödeme Tarihi
Mar 30, 2023
$7.00
Mar 31, 2023
Jun 28, 2023
Sep 29, 2022
$14.00
Sep 30, 2022
Dec 1, 2022
Mar 30, 2022
$14.00
Mar 31, 2022
Jun 24, 2022
Sep 29, 2021
$14.00
Sep 30, 2021
Dec 1, 2021
Mar 30, 2021
$14.00
Mar 31, 2021
Jun 25, 2021
Sep 29, 2020
$14.00
Sep 30, 2020
Dec 1, 2020
Dividend Grafikleri
DNPUF Kâr Payları
DNPUF Dividend Growth (Yıllık Üstünlük)
Follow-Up Questions
Sumitomo Pharma Co., Ltd.'in şu anki temettü ödemesi ve yıllık temettüsü nedir?
Sumitomo Pharma Co., Ltd.'in temettü ödeme oranı nedir?
DNPUF'ün temettü dağıtım tarihi nedir?
Sumitomo Pharma Co., Ltd. ne sıklıkla temettü öder?